Ketamine as an alternative to ECT in catatonia in elderly women with bipolar disorder: A case report

Frontiers in Psychiatry

Psychiatry

Shanthi Sarma¹  Arulmathy Arunachalam¹  Memunatu Kamara¹  Grace Branjerdporn² 

[1] Gold Coast Hospital and Health Service, Gold Coast, QLD, Australia;null;

关键词: ketamine;    catatonia;    COVID-19;    electroconvulsive therapy (ECT);    depression;    bipolar disorder;   

DOI  :  10.3389/fpsyt.2023.1138772

 received in 2023-01-06, accepted in 2023-03-21,  发布年份 2023

来源: Frontiers

【 摘 要 】

The following paper described two cases of patients with catatonic depression in bipolar disorder (BD) referred to our electroconvulsive therapy (ECT) service. Both were deemed not medically fit for ECT, and were, instead, treated with intravenous (IV) ketamine. Both responded with a resolution of symptoms, returning to baseline level of functioning. During the COVID-19 pandemic, given the risks associated with providing ECT (an aerosol generating procedure) and, in the context of limited resources, ketamine therapy for catatonia is a potentially beneficial alternative or supportive treatment to ECT that merits additional research.

【 授权许可】

Unknown   
Copyright © 2023 Sarma, Arunachalam, Kamara and Branjerdporn.